DE69721824D1 - Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen - Google Patents

Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen

Info

Publication number: DE69721824D1
Authority: DE; Germany
Prior art keywords: macular; edems; carbonanhydrase; inhibitors; treatment
Prior art date: 1996-02-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69721824T

Other languages

English (en)

Other versions

DE69721824T2 (de

Inventor

Eric Sponsel

Alon Harris

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Indiana University Research and Technology Corp

Original Assignee

Indiana University Research and Technology Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-26

Filing date

1997-02-25

Publication date

2003-06-12

1996-03-18 Priority claimed from GBGB9605642.9A external-priority patent/GB9605642D0/en

1997-02-25 Application filed by Indiana University Research and Technology Corp filed Critical Indiana University Research and Technology Corp

2003-06-12 Application granted granted Critical

2003-06-12 Publication of DE69721824D1 publication Critical patent/DE69721824D1/de

2004-03-11 Publication of DE69721824T2 publication Critical patent/DE69721824T2/de

2017-02-26 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Eye Examination Apparatus (AREA)

DE69721824T 1996-02-26 1997-02-25 Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen Expired - Lifetime DE69721824T2 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US1225096P	1996-02-26	1996-02-26
US12250P		1996-02-26
GB9605642		1996-03-18
GBGB9605642.9A GB9605642D0 (en)	1996-03-18	1996-03-18	Treatment of macular edema
PCT/US1997/002874 WO1997030704A2 (en)	1996-02-26	1997-02-25	Use of carbonic anhydrase inhibitors for treating macular edema

Publications (2)

Publication Number	Publication Date
DE69721824D1 true DE69721824D1 (de)	2003-06-12
DE69721824T2 DE69721824T2 (de)	2004-03-11

Family

ID=26308946

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69721824T Expired - Lifetime DE69721824T2 (de)	1996-02-26	1997-02-25	Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen

Country Status (26)

Country	Link
EP (1)	EP0954305B9 (de)
JP (1)	JP4392481B2 (de)
KR (1)	KR100471586B1 (de)
CN (1)	CN1225582A (de)
AT (1)	ATE239468T1 (de)
AU (1)	AU727565B2 (de)
BG (1)	BG64525B1 (de)
BR (1)	BR9707674A (de)
CA (1)	CA2247063C (de)
CZ (1)	CZ299509B6 (de)
DE (1)	DE69721824T2 (de)
DK (1)	DK0954305T3 (de)
EA (1)	EA001681B1 (de)
EE (1)	EE03804B1 (de)
ES (1)	ES2199348T4 (de)
HU (1)	HU227161B1 (de)
IL (1)	IL125912A0 (de)
IS (1)	IS2053B (de)
MX (1)	MXPA98006961A (de)
NO (1)	NO320043B1 (de)
NZ (1)	NZ331843A (de)
PT (1)	PT954305E (de)
SK (1)	SK284371B6 (de)
TR (1)	TR199801665T2 (de)
WO (1)	WO1997030704A2 (de)
YU (1)	YU49422B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9716657D0 (en)	1997-08-07	1997-10-15	Zeneca Ltd	Chemical compounds
GB9803226D0 (en)	1998-02-17	1998-04-08	Zeneca Ltd	Chemical compounds
WO1999044603A1 (en) *	1998-03-06	1999-09-10	Sponsel William E	Composition and method for treating macular disorders
US5948801A (en) *	1998-03-09	1999-09-07	Alcon Laboratories, Inc.	Treatment of retinal edema with brinzolamide
CN1311684A (zh) *	1998-07-10	2001-09-05	悉尼大学	黄斑变性中新生血管形成的预防治疗
GB9902455D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902453D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902452D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902461D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB9902459D0 (en)	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB0000625D0 (en)	2000-01-13	2000-03-01	Zeneca Ltd	Chemical compounds
US20030100594A1 (en) *	2001-08-10	2003-05-29	Pharmacia Corporation	Carbonic anhydrase inhibitor
EP2097421A2 (de)	2006-12-15	2009-09-09	Nicox S.A.	Carboanhydrasehemmerderivate
AR084194A1 (es) *	2010-12-09	2013-04-24	Fovea Pharmaceuticals	Derivados de arilsulfonamida para la prevencion o el tratamiento de trastornos oftalmologicos especificos
EP3559005A1 (de)	2016-12-21	2019-10-30	Biotheryx Inc.	Thienopyrrolderivate zur verwendung beim targeting von proteinen, zusammensetzungen, verfahren und verwendungen davon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4797413A (en) *	1986-05-14	1989-01-10	Merck & Co., Inc.	Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
GB2223166B (en) *	1988-09-29	1992-03-18	American Cyanamid Co	Stable ophthalmic preparations containing methazolamide
US5153192A (en) *	1990-04-09	1992-10-06	Alcon Laboratories, Inc.	Thiophene sulfonamides useful as carbonic anhydrase inhibitors

1997
- 1997-02-25 SK SK1151-98A patent/SK284371B6/sk not_active IP Right Cessation
- 1997-02-25 CA CA002247063A patent/CA2247063C/en not_active Expired - Fee Related
- 1997-02-25 EP EP97907822A patent/EP0954305B9/de not_active Expired - Lifetime
- 1997-02-25 AU AU19721/97A patent/AU727565B2/en not_active Ceased
- 1997-02-25 IL IL12591297A patent/IL125912A0/xx not_active IP Right Cessation
- 1997-02-25 DK DK97907822T patent/DK0954305T3/da active
- 1997-02-25 DE DE69721824T patent/DE69721824T2/de not_active Expired - Lifetime
- 1997-02-25 AT AT97907822T patent/ATE239468T1/de not_active IP Right Cessation
- 1997-02-25 CZ CZ0269998A patent/CZ299509B6/cs not_active IP Right Cessation
- 1997-02-25 MX MXPA98006961A patent/MXPA98006961A/es active IP Right Grant
- 1997-02-25 BR BR9707674-0A patent/BR9707674A/pt not_active Application Discontinuation
- 1997-02-25 HU HU9902054A patent/HU227161B1/hu not_active IP Right Cessation
- 1997-02-25 WO PCT/US1997/002874 patent/WO1997030704A2/en active IP Right Grant
- 1997-02-25 ES ES97907822T patent/ES2199348T4/es not_active Expired - Lifetime
- 1997-02-25 JP JP53037997A patent/JP4392481B2/ja not_active Expired - Fee Related
- 1997-02-25 EA EA199800764A patent/EA001681B1/ru not_active IP Right Cessation
- 1997-02-25 CN CN97192579A patent/CN1225582A/zh active Pending
- 1997-02-25 TR TR1998/01665T patent/TR199801665T2/xx unknown
- 1997-02-25 NZ NZ331843A patent/NZ331843A/xx not_active IP Right Cessation
- 1997-02-25 YU YU35398A patent/YU49422B/sh unknown
- 1997-02-25 EE EE9800263A patent/EE03804B1/xx not_active IP Right Cessation
- 1997-02-25 PT PT97907822T patent/PT954305E/pt unknown
- 1997-02-25 KR KR10-1998-0706643A patent/KR100471586B1/ko not_active Expired - Fee Related
1998
- 1998-08-20 IS IS4829A patent/IS2053B/is unknown
- 1998-08-25 NO NO19983906A patent/NO320043B1/no not_active IP Right Cessation
- 1998-09-25 BG BG102797A patent/BG64525B1/bg unknown

Also Published As

Publication number	Publication date
BR9707674A (pt)	2000-01-04
AU727565B2 (en)	2000-12-14
NZ331843A (en)	2000-09-29
EA199800764A1 (ru)	1999-06-24
WO1997030704A2 (en)	1997-08-28
NO983906D0 (no)	1998-08-25
EA001681B1 (ru)	2001-06-25
CN1225582A (zh)	1999-08-11
YU49422B (sh)	2006-01-16
ES2199348T4 (es)	2010-10-19
MXPA98006961A (es)	2004-11-19
CZ299509B6 (cs)	2008-08-20
YU35398A (sh)	2001-12-26
SK115198A3 (en)	2000-01-18
BG64525B1 (bg)	2005-06-30
TR199801665T2 (xx)	1998-12-21
EE9800263A (et)	1999-08-16
NO983906L (no)	1998-10-19
EP0954305B1 (de)	2003-05-07
JP4392481B2 (ja)	2010-01-06
AU1972197A (en)	1997-09-10
BG102797A (en)	1999-09-30
ATE239468T1 (de)	2003-05-15
HUP9902054A3 (en)	2001-07-30
EE03804B1 (et)	2002-08-15
DK0954305T3 (da)	2003-08-25
NO320043B1 (no)	2005-10-17
IS4829A (is)	1998-08-20
EP0954305A2 (de)	1999-11-10
JP2000506833A (ja)	2000-06-06
CZ269998A3 (cs)	2000-01-12
CA2247063A1 (en)	1997-08-28
DE69721824T2 (de)	2004-03-11
KR100471586B1 (ko)	2005-07-11
WO1997030704A3 (en)	1997-09-25
EP0954305B9 (de)	2010-08-04
KR19990087242A (ko)	1999-12-15
PT954305E (pt)	2003-09-30
HU227161B1 (en)	2010-09-28
HUP9902054A1 (hu)	2000-03-28
IL125912A0 (en)	1999-04-11
CA2247063C (en)	2004-01-06
ES2199348T3 (es)	2004-02-16
SK284371B6 (sk)	2005-02-04
IS2053B (is)	2005-10-14

Publication	Publication Date	Title
DE69721824D1 (de)	2003-06-12	Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen
DE69924641D1 (de)	2005-05-12	Behandlung von asthma anhand von mek-inhibitoren
ATE230606T1 (de)	2003-01-15	Verfahren zur vorbeugung und behandlung von allergien
EP0810884A4 (de)	2002-05-08	Verfahren zur behandlung von gefässthrombose und -restenose durch inhalieren von stickoxid
DK0719154T3 (da)	2001-11-26	Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel
DE69430309D1 (de)	2002-05-08	Dilatationskatheter und verfahren zur behandlung damit
ATE93138T1 (de)	1993-09-15	Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
DE69616376D1 (de)	2001-11-29	Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE69805973D1 (de)	2002-07-18	Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
ATE411018T1 (de)	2008-10-15	Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
DE68917433D1 (de)	1994-09-15	Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel.
DE69431199D1 (de)	2002-09-26	Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ATE225171T1 (de)	2002-10-15	Aminosäurederivate zur behandlung von schlaganfall
DE69432626D1 (de)	2003-06-12	Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen
UA66757C2 (en)	2004-06-15	Ophthalmologic composition of carbonic anhydrase inhibitors, method for treating or preventing macular edema or age-related macular degeneration
ATE251462T1 (de)	2003-10-15	Verfahren zur behandlung von narbengewebe
EE9700350A (et)	1998-10-15	COMT-inhibiitorite uus kasutamine ja diabeetiliste vaskulaarsete häirete ärahoidmise meetod
DE69502412D1 (de)	1998-06-18	Abgasbehandlungsmittel und Verfahren zur Behandlung von Abgas damit
DE69733321D1 (de)	2005-06-23	Olanzapine zur behandlung von drogenmissbrauch
ATE209861T1 (de)	2001-12-15	Verfahren zur behandlung von gefrorenen blattgemüse-portionen
RU94042315A (ru)	1996-09-20	Способ лечения язвенной болезни желудка и двенадцатиперстной кишки
NO984198L (no)	1998-11-02	FremgangsmÕte for behandling av aggresjon
ATA82393A (de)	1994-01-15	Verfahren zur behandlung von gasen
UA9553A (uk)	1996-09-30	Спосіб аутодермопластики коптюха

Legal Events

Date	Code	Title	Description
2004-01-22	8327	Change in the person/name/address of the patent owner	Owner name: ADVANCED RESEARCH & TECHNOLOGY INSTITUTE, INDIANAP
2004-06-03	8364	No opposition during term of opposition